Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the french acute lymphoblastic leukaemia group (FRALLE)

British Journal of Cancer

Volumn 83, Issue 12, 2000, Pages 1617-1622

  Donadieu, J ^a,b   Auclerc, M F ^c   Baruchel, A ^c   Perel, Y ^d   Bordigoni, P ^e   Landman Parker, J ^b   Leblanc, T ^c   Cornu, G ^f   Sommelet, D ^e   Leverger, G ^b   Schaison, G ^c   Hill, C ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d HÔPITAL PELLEGRIN   (France)

^e CHU NANCY BRABOIS   (France)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Acute lymphoblastic leukaemia; Childhood; Continuous variable; Cutpoint; Prognostic factors

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ARTICLE; BLAST CELL; CANCER MORTALITY; CANCER RISK; CHILD; CHILDHOOD CANCER; CLINICAL PROTOCOL; HEMOGLOBIN DETERMINATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; THROMBOCYTE COUNT;

ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC AGENTS; CELL COUNT; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELLS; HEMOGLOBINS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKOCYTE COUNT; PLATELET COUNT; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TIME FACTORS;

EID: 17744396457     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1504     Document Type: Article

References (28)

1. Danger of using 'optimal' cutpoints in the evaluation of prognostic factors
2. Remaining problems in the staging and treatment of childhood lymphoblastic leukemia
3. The staging of childhood acute lymphoblastic leukemia: Strategies of the Childrens Cancer Study Group and a three-dimensional technic of multivariate analysis
4. Die akute lymphoblastiche leukamie im Sauglingsalter: Eregebnissse aus funf multisentrischen therapiestudien ALL-BFM 1970-1986
5. Intensification of treatment and survival in all children with lymphoblastic leukaemia: Results of UK medical research council UKALL X
6. Regression models and life tables (with discussion)
7. Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: Differences in outcome are poorly explained by the most significant prognostic variables
8. Floating absolute risk: An alternative to relative risk in survival and case control analysis avoiding an arbitrary reference group
9. The Will Rogers phenomenon: Stage migration and new diagnosis techniques as a source of misleading statistics for survival in cancer
10. Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: The Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology
11. Valeur pronostique d'une variable continue et point de cesure optimal
12. Why do so many prognostic factors fail to pan out?
13. Prognostic factors in children with acute lymphoblastic leukemia. Part II: Multivariate analysis
14. Prognosis and treatment of acute lymphoblastic leukemia
15. The problem of 'staging' in childhood acute lymphoblastic leukemia: A review
16. Report and recommendations of the Rome workshop concerning poor-prognosis ALL in children: Biologic bases for staging, stratification, and treatment
17. Chemotherapy of 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trail ALL-BFM 86
18. Assessment of the interrelationship of prognostic factors in childhood acute lymphoblastic leukemia
19. Regression using fractional polynomials of continuous covariates: Parsimonious parametric modelling
20. Building multivariable prognostic and diagnostic models: Transformation of the predictors by using fractional polynomials
21. Treatment of acute lymphoblastic leukemia: Protocol Fralle 83-85
22. A note on quantifying follow-up in studies of failure time
23. Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber Cancer Institute/Children's hospital acute lymphoblastic leukemia consortium protocol 85-01
24. Treatment of acute lymphobiastic leukemia in childhood and adolescence: Results of the multicenter therapy study ALL-BFM 81
25. Uniform approach to risk-classification and treatment assignment for children with ALL
26. Prognosis for survival in the leukemias of childhood
27. Implications of long-term survival in acute stem cell leukemia of childhood treated with composite cyclic therapy